Oligonucleotides, composed of 2 to 20 nucleotide units, are increasingly utilized in disease diagnosis and therapeutic applications. They facilitate the introduction of DNA into immune cells, enabling genetic modifications to express chimeric antigen receptor proteins for cell-based immunotherapy.